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Background: The purpose of this study was to evaluate the gender-related changes in the function and distribution 
of α1-adrenoceptors in the distal mesenteric artery of streptozotocin (STZ)-induced diabetic rats at the level of α1-
adrenoceptor subtypes. 
Methods: Diabetes was induced by intravenous injection of STZ in a dose of 60 mg/kg through the tail vein in 8 week-
old male or female Sprague-Dawley rats (n = 13/group). Age-matched normal rats (n = 15) were used as a control 
group. Four weeks after STZ injection, the change in mean arterial pressure caused by a 45
o tilting was recorded. The 
α1-adrenoceptor subtypes mediating contractions of the distal mesenteric artery were investigated using the agonist, 
phenylephrine as well as subtype-selective antagonists including prazocin, 5-methylurapidil, and BMY 7378. The 
expression of α1-adrenoceptor subtypes of each artery was examined by immunofluorescence staining and western 
blotting using subtype selective antibodies. 
Results: Compared with normal male rats, the contractile response to phenylephrine was decreased in the distal 
mesenteric artery in normal female rats. Moreover, a decrease in contractile force was observed in STZ-induced 
diabetic rats compared with age-matched controls. Western blotting revealed that there was the difference between 
normal male and female rats in manifestation of the α1D-adrenoceptor. In STZ-induced male and female diabetic rats, 
all α1-adrenoceptor subtypes were decreased in distal mesenteric arteries, compared with normal rats. 
Conclusions: There was the gender-related functional difference of α1-adrenoceptors in normal rats. In both male 
and female rats, diabetes decreased the contractile response in mesenteric arteries, which might be caused by the 
overall change in α1-adrenoceptor. (Korean J Anesthesiol 2011; 61: 419-427)
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Introduction
There are increasing evidences that alterations induced by 
diabetes in the cardiovascular autonomic system may show 
gender differences [1]. Generally, cardiovascular diseases 
are more frequently found in men than premenopausal 
women [2]. However, in the diabetic patients, the incidence 
of cardiovascular disease becomes similar between men and 
women because diabetes may produce a relatively greater 
impairment in the female cardiovascular system [1]. In 
addition, in female rats, more severe diabetic-induced vascular 
impairment was developed than in male rats by impaired 
sympathetic mediated vasoconstriction or increase the 
relaxation to nitric oxide [3].
The activity of vascular sympathetic nervous system is 
regulated by adreneral hormone, several neurotransmitters and 
interaction with these factors via α1-, α2- and β-adrenoceptors 
[4]. In blood vessels, post-junctional α1-adrenoceptors play 
an important role in controlling vascular smooth muscle 
tone and thus modulate peripheral arterial resistance [5-7]. 
Radioligand binding, molecular cloning studies and isolated 
tissue experiments have identified three α1-adrenoceptor 
subtypes that are designated α1A, α1B, and α1D [8,9] and the 
functional dominance in adrenergic responses varies with 
tissue and species [10]. Considering these findings, diabetes-
induced functional and distributional changes in the vascular 
α1-adrenoceptor can play a role in the pathogenesis of diabetic 
vascular disturbances, depending on the gender difference.
However, to our knowledge, there has been no investigation 
on how the α1-adrenoceptor subtypes change during the 
development of diabetic autonomic neuropathy depending on 
the gender. Therefore, we evaluated the effect of diabetes on 
function and distribution of the vascular α1-adrenoceptor using 
the distal mesenteric artery in streptozotocin (STZ)-induced 
diabetic male and female rats.
Materials and Methods 
Animals 
Twenty-eight male and female Sprague-Dawley rats (8 weeks 
old, 200-250 g) were used. All animal studies were carried out 
in a semi-pathogen-free barrier zone at Institute for Laboratory 
Animal Research in accordance with the procedures outlined in 
the Guide for the Care and Use of Laboratory Animals. 
Induction of diabetes mellitus
Male or female rats were randomly allocated into either 
the control group (n = 15) or diabetic group (n = 13). Diabetes 
was induced by a single intravenous tail vein injection of 60 
mg/kg streptozotocin (STZ) dissolved in citrate buffer at pH 
4.5. In the age-matched control groups, the same volume of 
citrate buffer was injected intravenously. All rats were housed 
in cages and allowed free access to food and water. Three days 
thereafter, blood glucose levels were measured from a drop of 
blood taken from the tail using OneTouch Ultra
Ⓡ Blood Glucose 
Meter (LifeScan, Inc). Rats with blood glucose >300 mg/dl 
were considered diabetic. All rats were maintained for 4 weeks 
without intervention.
Changes in arterial blood pressure related to tilting
Four weeks after STZ or citrate buffer injection, blood 
glucoses levels and body weights were measured. Body weights 
and blood glucose levels in normal and diabetic rats are shown 
in Table 1. Anesthesia was induced with sevoflurane-oxygen in 
a chamber and maintained with 2 vol% sevoflurane. Following 
anesthesia, rats were positioned in the supine position and 
four legs were firmly fixed on a tilt board. The tail artery was 
cannulated with a 24 G catheter for continuous arterial pressure 
monitoring. The transducer was positioned at the level of the 
heart. After measuring mean arterial pressure in the supine 
position (basal MAP), the table was vertically tilted at 45
o angle 
in a head-up direction and MAP at 10, 30, 60, and 120 seconds 
after tilting were recorded. Changes in MAP related to tilting 
were compared at each time point between diabetic and control 
groups. 
Preparation of vascular tissues
After the tilting experiment, the rat was euthanized by cervical 
dislocation under deep anesthesia and the third branch of 
mesenteric artery was dissected. Arteries were placed in a Petri 
Table 1. Body Weights and Blood Glucose Levels in Normal and Diabetic Rats
Weight (g) Glucose level (mg/dl)














Data are presented as means ± SD. *P < 0.001 vs. male rats, 
†P < 0.001 vs. normal rats.421 www.ekja.org
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dish with ice-cold modified Krebs’ solution of the following 
composition (in mM): NaCl, 119; KCl, 4.7; MgSO4, 1.17; NaHCO3, 
22; CaCl2, 1.6; HEPES, 8; KH2PO4, 1.18; d-glucose, 5. The artery 
was cleaned of fat and connective tissues under a microscope 
(Zeiss, Germany). To exclude the effect of endothelium-derived 
relaxing factor, the endothelium of the arteries was denuded 
by passing silk through the lumen. Thereafter, each artery 
was cut into 3 mm long rings for in vitro contractile studies. 
The remaining vessels were immediately stored at -80
oC for 
immunofluorescence staining and western blotting. 
Measurements of isometric tension
Each vascular segment, suspended between two triangle-
shape tungsten hooks, was mounted in a 5 ml water-jacketed 
temperature-controlled tissue bath (Harvard Apparatus, Holliston, 
USA) containing modified Krebs’ solution. The lower and 
upper hooks were fixed to the bottom of the bath chamber and 
to a force displacement transducer, respectively (NP 72-4493, 
Harvard Apparatus, Holliston, USA). The tissue bathing solution 
was equilibrated and suspended with a mixture of 95% O2 and 
5% CO2 (pH: 7.38-7.42, pCO2: 34-36 mmHg) and maintained 
at 37
oC. Propranolol (1 × 10
-6 M) and yohimbine (1 × 10
-7 M) 
were always included in the tissue bathing solution to block 
β- and α2- adrenoceptors, respectively. Changes in isometric 
force were recorded through an A/D converter (Powerlab
Ⓡ, 
ADInstruments, Colorado Springs, USA) and analyzed by using 
Chart for Window Software
Ⓡ (ADInstruments, Colorado Springs, 
USA). Following an initial tension of 2.0 g, which provided the 
optimum concentration-response relationships to KCl 60 mM, 
the arterial strips were allowed to equilibrate for 60 min. When 
the resting tension reached a stable baseline, no attempt was 
made to adjust tissue tension. After the equilibrium, tissues 
were primed by the addition of phenylephrine (1 × 10
-6 M) to 
the organ bath. After a steady-state contraction was achieved, 
bath contents were replaced with modified Krebs’ solution 
several times. Tissues were then allowed to reach baseline 
tension and the priming procedure was repeated once more 
before constructing concentration-response curves. This 
priming procedure reduces tissue variability in response to 
repeated agonist administration. In addition, the absence of 
functional endothelium was also confirmed by the loss of the 
relaxation response to acethylcholine (1 × 10
-6 M) in the pre-
contracted rings with a priming dose of phenylephrine (1 × 10
-6 
M) during the priming procedure. 
Construction of concentration-response curves
Reproducible cumulative concentration-response curves 
were constructed by exposing each artery to increasing con-
centrations of phenlyephrine (1 × 10
-9 to 1 × 10
-4 M  at 0.5 log 
unit increments) until a sustained maximum response (Emax) 
was observed. Concentration-response curves to phenylephrine 
were then obtained (each at 60 min apart) in the presence 
of three selective α1-adrenoceptor antagonists to each artery 
and the procedure was repeated with a high concentration of 
antagonists in the same preparation. The incubation time for 
selective α1-adrenoceptor antagonists, prazosin (α1; 1, 3, and 
10 × 10
-9 M), 5-methylurapidil (5-MU; α1A; 3, 10, and 30 × 10
-8 
M), and BMY 7378 (α1D; 3, 10, and 30 × 10
-8 M) was 30 min. 
Propranolol (1 × 10
-6 M) and yohimbine (1 × 10
-7 M) were 
always included in the tissue bath solutions to block β - and α2-
adrenoceptors, respectively.
Immunofluorescence staining
After removing vessels and cleaning extraneous tissues, 
Hematoxylin and eosin (H&E) staining was used to assess 
the morphologic changes. Arteries were cut into 2-mm rings, 
embedded in OCT compound (Tissue-Tek
Ⓡ OCT
TM Compound, 
Sakura Finetek, Japan) and quickly frozen (-50
oC in isopentane 
cooled with dry ice). Frozen blocks were cut into 5-μm sections 
and mounted on a slide. All sections were stored at -80
oC until 
use. After warming at room temperature for 30 minutes, the 
tissue sections were fixed in ice cold acetone for 5 minutes. 
After rinsing the sections in PBS, a blocking solution with 10% 
normal donkey serum was placed on the sections and then 
incubated for 30 minutes to block non-specific binding sites of 
immunoglobulin. After removal of the blocking solution, the 
tissue section was incubated with 1 : 100-diluted the primary 
antibody (α1D-AR cat. no. s.c.-1475, α1A-AR cat. no. s.c.-1477; 
Santa Cruz Biotechnology, Santa Cruz, USA) for 60 minutes at 
room temperature. After washing the primary antibody in PBS, 
fluoresceinisothiocyanate (FITC)-conjugated donkey anti-goat 
IgG (1 : 100 dilution, no. s.c.-2024; Santa Cruz Biotechnology) 
secondary antibody was placed on the sections for 60 minutes 
in the dark at room temperature. After removing secondary 
antibody by washing with PBS, mounting media was placed 
on the slide and a glass coverslip was adhered. To reduce 
the technical error, staining was performed on as same slide 
for each type of artery from each group. Three independent 
investigators observed the expression of α1-adrenoceptor 
subtypes of each artery with a fluorescence microscope 
(Olympus VENOX-AHBT3, Tokyo, Japan).
Western blotting
Isolated vascular segments were homogenized in lysis buffer 
(1% Nonidet-40, 20 mM Tris-HCl [pH 7.4], 150 mM NaCl, 1 
mM Ethylenediaminetetracetic acid [EDTA], 0.1% SDS and 2 422 www.ekja.org
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mM Phenylmethylsulfonyl fluoride [PMSF]). The sample was 
centrifuged at 12,000 g for 15 min at 4
oC and the supernatant 
was extracted. Protein concentrations were determined using 
the method of Sambrook and Russel [11]. Samples containing 
180 ug of protein were boiled for 5 min to extract membrane 
proteins, loaded and electrophoresed on SDS-Polyacrolamide 
gels (PAGE), transferred to PVDF and then blocked for 1 h 
with 5% nonfat dry milk in tris-buffered saline with tween 
(TBST
Ⓡ; 20 mM Tris-HCl, pH 7.4, 150 mM NaCl, 0.05% Tween 
20) for 1 hr at room temperature. Commercially available 
polyclonal antibodies to α1A- and α1D-adrenergic receptors 
(α1A-AR cat. no. s.c.-1477, α1D-AR cat. no. s.c.-1475; Santa Cruz 
Biotechnology) were applied to membranes (1 : 500 in TBST) 
overnight at 4
oC. The membranes were washed with TBST
Ⓡ 
and secondary antibody diluted to 1 : 4,000 (Horse-radish 
peroxidase conjugated donkey anti-gout IgG; no. s.c.-2020; 
Santa Cruz Biotechnology) was incubated in room temperature 
with the membranes. After washing with TBST
Ⓡ, binding of 
the antibodies was detected with Chemiluminescent (ECL
Ⓡ, 
Amersham, Little Chalfont, Buckinghamshire, UK). 
Statistical analysis
Data are presented as means ± SD, means ± SEM, number 
of rats, or number of arterial segments. In each concentration-
response curve, the changes in tension related to increasing 
concentrations of phenylephrine are expressed as the difference 
of tension (g) between the basal values and the measured value 
with various concentrations of phenylephrine. Curves were 
fitted to all the data by non-linear regression using GraphPad 
Prism software (GraphPAD software, San Diego, USA) to 
calculate the negative logarithm of the concentration of agonist 
that provokes a half-maximal response (pEC50 = agonist 
potency). A pA2 value and Schild slopes were calculated by the 
method of Arunlakshana and Schild [12]. Using three different 
concentrations of each antagonist, the ratios between the half-
maximal concentrations (EC50) of phenylephrine obtained 
with the specific antagonist concentration and that obtained in 
its absence (concentration ratio, R) were calculated when the 
maximal amplitudes between concentration-response curves 
in those two conditions were similar. Data were plotted as 
negative log-concentrations of the antagonist on the x-axis vs. 
log (R-1) on y-axis and fitted as a regression line. For calculation 
purposes, the slope parameter was set to -1.0 when statistically 
not different from unity. The x-intercept of the fitted regression 
line was an estimated pA2. The value of pA2 presented a 
logarithmic measurement of the potency of the specific 
antagonist and also the dose of antagonist that required a 2-fold 
increase in agonist concentration. Data were compared by 
two-way ANOVA, followed by unpaired Student t test with the 
Bonferroni correction for multiple comparisons, to determine 
which comparisons were statistically significant. Data were 
considered significantly different at values of P < 0.05.
Results 
Induction of diabetes mellitus and changes in arterial 
blood pressure related to tilting
Diabetic rats showed significantly higher blood glucose 
concentrations and lower body weight than age-matched 
normal rats (Table 1, all P < 0.001). After a 45
o tilting in the 
head-up direction, recovery of MAP was significantly slower in 
Fig. 1. Time course for the change in mean arterial pressure (MAP) 
after tilting in normal male (■), normal female (▲), streptozotocin-
induced diabetic male (□) and diabetic female (△) rats. Each data 
point represents means ± SD. Data from 13 rats were collected in 
each group. *P < 0.001 vs. diabetic rats. 
†P < 0.05 vs. normal rats, 
‡P 
< 0.01 vs. male rats.
Table 2. Maximal Response (Emax) and -logEC50 Values for Phenylephrine-Induced Contraction of Distal Mesenteric Arteries from Normal 
and Streptozotocin-Induced Diabetic Rats
Normal rats Diabetic rats














Data are presented as means ± SD. EC50, the concentration of agonist that provokes a half-maximal response in the concentration-response 
curve. *P < 0.001 vs. male rats, 
†P < 0.001 vs. normal rats.423 www.ekja.org
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diabetic rats than in normal rats and recovery in normal female 
rats were significantly slower than in normal male rats (Fig. 1, 
all P < 0.05). 
Concentration-response curves
The concentration-response curves for phenylephrine-
induced contraction of normal mesenteric artery showed 
that the Emax and -logEC50 in female rats were significantly 
lower than those in male rats (Table 2). Diabetic rats had the 
significantly lower Emax and -logEC50 than normal rats. 
Further, the Emax in diabetic female group was lower than that 
in diabetic male group but there was no significant difference in 
the -logEC50 (Table 2).
Regardless of arterial type, prazocin, 5-MU, and BMY 
7378 shifted the concentration-response curve according to 
phenylephrine to the right in both diabetic and normal rats. 
In addition, pA2 values for prazocin, 5-MU, and BMY 7378 for 
inhibiting the contractile response to phenylephrine decreased 
by a similar order of magnitude in distal mesenteric arteries 
Table 3. The pA2 Values Against Phenylephrine in Male or Female Distal Mesenteric Arteries from Normal and Streptozotocin-Induced Diabetic Rats
Male rats Female rats





















Data are expressed as means ± SD. The value of pA2 represents a logarithmic measurement of the potency of the specific antagonist and also 
the dose of antagonist that required a 2-fold increase in agonist concentration. 5-MU: 5-methylurapidil. *P < 0.001 vs. male rats. 
†P < 0.001 vs. 
normal rats.  
Fig. 2. Hematoxylin and eosin stained 
images in male (A, B) and female 
mesenteric arteries (C, D) from normal 
and streptozotocin-induced diabetic 
rats. (magnification: ×200). Mesenteric 
arteries from diabetic rats were 
characterized by a decrease in density 
of muscle fiber at the media of the 
vessel wall.424 www.ekja.org
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from diabetic rats (all P < 0.001, Table 3). In normal female rats, 
the pA2 value for BMY 7378 was significantly smaller than in 
normal male rats.
Immunofluorescence staining and Western blotting
H & E staining images in male and female mesenteric arteries 
from normal and streptozotocin-induced diabetic rats showed 
that diabetic mesenteric arteries were characterized by a 
decrease in density of muscle fiber at the media of the vessel 
wall (Fig. 2). Immunofluorescence images of α1A- and α1D-adre-
noceptor subtypes in mesenteric arteries of diabetic rats were 
characterized by a decreased fluorescent intensity (Fig. 3 and 4). 
The α1D-adrenoceptor subtype was expressed less in female 
normal rats than in male normal rats (Fig. 5). In diabetic rats, 
the expressions of the α1A- and α1D-adrenoceptor subtypes 
were decreased compared with those in the gender-matched 
normal rats (all P < 0.05). In particular, in female diabetic rats, 
the expression of alpha 1D - receptors was not detectable above 
background. 
Discussion 
The results of our study showed that diabetes impaired 
the MAP recovery after tilting irrespective of gender and the 
MAP changes after tilting were different between normal 
male and female rats. The concentration-response curves for 
phenylephrine-induced contraction of normal female mesen-
teric artery showed that the adrenergic-mediated vasocon-
traction was impaired via difference in α1D-adrenoceptor 
expression. In diabetic rats, the adrenergic mediated 
vasocontraction was decreased irrespective of gender, 
which might be caused by the general decrease in overall α1-
adrenoceptor subtype expression. 
Vascular α1-adrenoceptor plays a primary role in maintaining 
systemic arterial pressure and arteriolar resistance [5-7]. Recent 
studies have shown that the α1D-adrenoceptor plays a major 
role in vasoconstriction of mesenteric arteries [13,14] and that 
the α1A-adrenoceptor is responsible for vascular contraction 
in distal mesenteric arteries [13]. A number of studies have 
demonstrated vascular differences depending of gender. Nitric 
Fig. 3. Immunofluorescence images of 
the α1A-adrenoceptor subtype in male 
(A, B) and female mesenteric arteries 
(C, D) from normal and streptozotocin-
induced diabetic rats. (magnification: 
×200). Diabetic mesenteric arteries 
were characterized by a decreased fluo-
rescent intensity.425 www.ekja.org
Korean J Anesthesiol Park, et al.
oxide release which is an important endothelium-derived 
vasodilator regulating the vasomotor tone [15] depends on 
circulating estradiol concentrations [16]. In addition, estrogen 
decreases resistance artery adrenergic sensitivity by increasing 
the basal release of relaxing factors from the endothelium [17]. 
Our results in normal rats were comparable to a previous study 
[18] in which that the contractile responses to phenylephrine 
were significantly increased by endothelium disruption in 
arteries in males but not females. A possible explanation is 
that there was a significant difference in the pA2 for the α1D-
adrenoceptor and normal female rats showed a relatively 
suppressed manifestation of α1D-adrenoceptor than normal 
males in immunofluorescence and western blotting. Similar 
to our results, the expression of α1D - adrenergic receptors was 
significantly suppressed by estradiol replacement [19]. 
Diabetic male or female rats had a 15% lower Emax and 5 
or 2 times higher EC50 for phenylephrine than did the controls. 
These were in close accordance with our immunofluorescence 
staining and western blotting results. There were some 
discrepancies about the adrenergic responses of the mesenteric 
arteries of STZ-rats. The conflicting results could be due to 
differences in the vascular responses between the superior 
mesenteric arteries and small mesenteric arteries as well as 
the intact mesenteric bed, where the latter more reflects the 
resistance arteries [20]. In addition, diabetic female mesenteric 
arteries had a 20% lower Emax than diabetic male. These results 
were similar with previous investigations in which contractile 
responses to phenylnephrine were higher in diabetic males 
than in female rats [21] and the sensitivity to adrenergic nerve 
stimulation was greater in males compared to females [22]. 
Diabetic rats showed impaired recovery from the tilt-induced 
decrease in blood pressure. This phenomenon is very comparable 
with orthostatic hypotension. Considering that orthostatic 
hypotension is the most serious clinical consequence of 
diabetes-induced vascular disturbances [23], our diabetic 
rat model would be appropriate for evaluating the effect of 
diabetes on the vascular alpha 1-adrenoceptor. In normal 
female rats, the MAP changes after tilting were significantly 
smaller than those in the other groups when assessed at 10 sec 
to 120 sec after tilting. On the contrary, most clinical studies 
report that the orthostatic hypotension in women occurs more 
frequently than normal men [24-26]. However, the smaller 
Fig. 4. Immunofluorescence images of 
the α1D-adrenoceptor subtype in male 
(A, B) and female mesenteric arteries 
(C, D) from normal and streptozotocin-
induced diabetic rats. (magnification: 
×200). Diabetic mesenteric arteries 
were characterized by a decreased fluo-
rescent intensity.426 www.ekja.org
Vol. 61, No. 5, November 2011 Gender difference of α1-adrenoceptor in diabetic rats
degree of MAP changes is in women [27,28] and only changes 
in systolic BP to stimuli has gender differences [29]. A possible 
explanation is that the effects of α2 and β-adrenoceptors cannot 
be ruled out in vivo because the activity of vascular sympathetic 
nervous system is regulated by interaction via α1-, α2- and 
β-adrenoceptors [4]. 
Our study has some limitations. First, the α1A and α1D 
subtypes were chosen on the basis of their physiological roles 
in vivo in this study. It is reported that the contractions of the 
rat mesenteric artery are mediated via the α1D and α1A-subtypes 
which werewas identified as the predominant subtypes in rat 
mesenteric arteries [13,14]. In contrast, it appears that the α1B-
subtype does not contribute to phenylephrine-induced pressor 
responses, nor may it be important for the maintenance of basal 
mean arterial pressure [30]. Second, 2 vol% sevoflurane may 
not result an equipotent depth of anesthesia between normal 
and diabetic rats when assessed in the tilting test. In diabetic 
rats, the decrease of vascular resistance by sevoflurane may be 
potentiated due to diabetes, which may make the difference 
greater. 
In conclusion, the adrenergic-mediated vasocontraction 
was impaired via the decrease of α1D-adrenoceptors in normal 
female mesenteric arteries. Progression of diabetes decreased 
the contractile response in mesenteric arteries in STZ-induced 
diabetic rats irrespective of gender, which might be caused by 
the overall change in α1-adrenoceptors and not from the change 
in specific α1-adrenoceptor subtypes. Our results on the gender 
differences may be helpful in understanding one of the complex 
pathophysiologic changes in vascular disturbance caused by 
diabetes.
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